[
  {
    "id": "b--t-cells_2008_1750165656.txt-1",
    "source_document": "b--t-cells_2008_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/lymphomanormalBcells.html#definitiongeneral105134",
    "clean_content": "Definition / general\n\n**B cells:**\n\n+ Progressive maturation of hematopoietic stem cells through several stages to ultimately give rise to mature B cell pool that has been selected for reactivity against non-self antigens ([Expert Rev Clin Immunol 2010;6:765](20828285))+ Develop from stem cells of yolk sac, fetal liver, spleen and bone marrow+ B cells complete most of their development within the bone marrow, in contrast to T cells that mature within the thymus+ In intersinusoidal bone marrow, hematopoietic stem cells mature to early lymphoid progenitors, the pro B, pre B stages+ Developmental stages are in close contact with slender CD10+ stromal cells or their extensions, which allows tightly regulated signaling ([J Pathol 2005;205:311](15682430))+ Earliest stem cells are in subendosteum, adjacent to inner bone surface; with maturation, B lineage cells move towards central axis of marrow; final stages of development of immature B cells occur in peripheral lymphoid organs (spleen, lymph nodes)\n\n  \n**T cells:**\n\n+ Develop from bone marrow, become prothymocytes, then migrate to thymus gland, where self recognizing T cells are eliminated"
  },
  {
    "id": "b--t-cells_2008_1750165656.txt-2",
    "source_document": "b--t-cells_2008_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Pathophysiology",
    "url": "https://www.pathologyoutlines.com/topic/lymphomanormalBcells.html#pathophysiology105135",
    "clean_content": "Pathophysiology\n\n**B cells:**\n\n+ B cells express surface immunoglobulin (Ig), composed of 2 heavy (H) and 2 light (L) chains (either kappa or lambda)+ B cell antigen receptor loci may have 4 types of modification: (a) recombination of variable, diversity and joining regions (VDJ); (b) somatic hypermutation of V segments; (c) immunoglobulin heavy chain gene class switching; and (d) receptor editing+ Early B cell precursor is TdT+, CD34+, HLA-DR+, then undergoes heavy (H) chain rearrangement and adds CD19, then adds CD10, then adds IgM heavy chain; then adds light (L) chain rearrangement and adds cytoplasmic IgM with heavy and light chains, then B cells express IgM and IgD with the same binding site, then adds CD20 (now called pre B cell); then adds surface Ig, then adds CD21 and CD22 and drops TdT (now called B cell)+ If B cell encounters an antigen that interacts with its variable region, it becomes a plasma cell+ Precursor B cells contain immunoglobulin related components but not immunoglobulin; express CD179a and CD179b (precursor to light chains) as part of their pre B cell receptor, which disappears when replaced with conventional light chains+ B cells express surface immunoglobulin, consisting of 2 heavy chains and 2 light chains (kappa or lambda); immunoglobulin is associated with CD79a / CD79b complex to form a B cell antigen receptor complex+ IgH gene (heavy chain of immunoglobulin) is at 14q32; variable portion is coded by VDJ regions+ IgL gene (light chain of immunoglobulin): kappa is at 2p11, lambda is at 22q11; no diversity region is present+ Heavy chain isotype switch: determines if immunoglobulin is IgM, IgD, IgG1-4, IgA1-2 or IgE (9 constant regions); mediated by switch genes\n\n  \n**T cells:**\n\n+ T cell receptors (TCR) are either alpha / beta (95%) or gamma / delta (5%) heterodimers+ T cell progenitors migrate to the thymus and undertake a highly ordered developmental program, regulated by signals derived from microenvironment+ Most immature thymocytes are CD4- / CD8- (\"double negative\" / DN); DN is divided into 4 stages based on CD44 / CD25 expression: DN1 is CD44+, CD25-; DN2 is CD44+, CD25+; DN3 is CD44-, CD25+; DN4 is CD44-, CD25- ([Immunol Res 2010;47:45](20082155))+ Precursor cell is TdT+, CD34+, HLA-DR+, then drops HLA-DR, then adds CD2, CD5, CD7 (early thymocyte) while undergoing gamma / beta chain rearrangement, then adds CD1 and drops CD34, now a common thymocyte (CD4-, CD8-, \"double negative\"), then undergoes beta / alpha chain rearrangement (DN3 stage) and adds CD4 and CD8, then splits into helper (CD4) or cytotoxic (CD8) T cell (\"single positive\") with CD2 and CD3, and without TdT, CD1, CD5 and CD7+ T alpha and delta genes are on 14q11; T beta gene is on 7q34; T gamma gene is on 7p15+ **Note**: T cells and NK cells arise from common progenitor that expresses CD3 epsilon and cannot develop into B cells"
  },
  {
    "id": "b--t-cells_2008_1750165656.txt-3",
    "source_document": "b--t-cells_2008_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Diagrams / tables",
    "url": "https://www.pathologyoutlines.com/topic/lymphomanormalBcells.html#diagramstables105136",
    "clean_content": "Diagrams / tables\n\nAFIP images  \n\n[![Missing Image](https://www.pathologyoutlines.com/images/lymph/04_01.jpg)](https://www.pathologyoutlines.com/images/lymph/04_01.jpg)\n\nB cell biomarker expression during development\n\n[![](https://www.pathologyoutlines.com/images/lymph/04_02.jpg)](https://www.pathologyoutlines.com/images/lymph/04_02.jpg)\n\nT cell biomarker expression during development\n\n  \n  \n  \nImages hosted on other servers:   \n\n[![](https://www.pathologyoutlines.com/thumb/lymphomanormalBcells_medscape01.gif)](http://img.medscape.com/fullsize/migrated/530/588/ncpn530588.fig1.gif)\n\nB cell development\n\n[![](https://www.pathologyoutlines.com/thumb/lymphomanormalBcells_wiki02.png)](https://en.wikipedia.org/wiki/File:B_cell_activation.png)\n\nB cell response to antigen\n\n[![](https://www.pathologyoutlines.com/thumb/lymphomanormalBcells_semantic03.png)](https://www.semanticscholar.org/paper/Microenvironmental-niches-in-the-bone-marrow-for-Nagasawa/e3a4138c0ba8c549b650c46c81a31241ab588158/figure/2)\n\nB cell biomarker expression during development\n\n[![](https://www.pathologyoutlines.com/thumb/lymphomanormalBcells_semantic04.png)](https://www.semanticscholar.org/paper/Microenvironmental-niches-in-the-bone-marrow-for-Nagasawa/e3a4138c0ba8c549b650c46c81a31241ab588158/figure/3\")\n\nMicroenvironmental  \n niches in the bone  \nmarrow required for  \nB cell development\n\n[![](https://www.pathologyoutlines.com/thumb/lymphomanormalTcells_wiki01.png)](https://en.wikipedia.org/wiki/File:T_cell_activation.png)\n\nT cell activation\n\n[![Missing Image](https://www.pathologyoutlines.com/thumb/lymphomanormalTcellsthumbimg01.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891409/figure/F1/)\n\nT cell development"
  },
  {
    "id": "b--t-cells_2008_1750165656.txt-4",
    "source_document": "b--t-cells_2008_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Clinical features",
    "url": "https://www.pathologyoutlines.com/topic/lymphomanormalBcells.html#clinicalfeatures105137",
    "clean_content": "Clinical features\n\n**B cells:**\n\n+ B cell lymphomas: a clonal light chain rearrangement is usually specific for the presence of a B cell neoplasm+ X linked agammaglobulinemia: no B cell development\n\n  \n**T cells:**\n\n+ Defects in receiving T cell signals can cause hyper IgM syndrome ([J Allergy Clin Immunol 2010;125:778](20371392))+ 90% of peripheral T cell lymphomas have rearrangements of T alpha, beta and gamma, including all cases of mycosis fungoides and Sezary syndrome+ T cell lymphomas have no distinct marker of clonality, but cells may express an abnormal immunophenotype or TCR gene rearrangement+ As there are only 10 V (variable) regions, a polyclonal population of cells can appear oligoclonal+ T cell clonality is seen in AIDS and congenital immunodeficiency syndromes, but does NOT indicate malignancy+ Rarely a clonal band may comigrate with the germline band; solution: use 2 - 3 restriction enzymes (HindIII, EcoRI, BamHI)"
  },
  {
    "id": "b--t-cells_2008_1750165656.txt-5",
    "source_document": "b--t-cells_2008_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Positive stains",
    "url": "https://www.pathologyoutlines.com/topic/lymphomanormalBcells.html#positivestains105138",
    "clean_content": "Positive stains\n\n* B cells: varies by developmental state, but typically [CD19](https://www.pathologyoutlines.com/topic/cdmarkerscd19.html), [CD20](https://www.pathologyoutlines.com/topic/cdmarkerscd20.html), [CD79a](https://www.pathologyoutlines.com/topic/cdmarkerscd79a.html)* T cells: [CD2](https://www.pathologyoutlines.com/topic/cdmarkerscd1.html#cd2), [CD3](https://www.pathologyoutlines.com/topic/cdmarkerscd3.html), [CD4](https://www.pathologyoutlines.com/topic/cdmarkerscd4.html) or [CD8](https://www.pathologyoutlines.com/topic/cdmarkerscd8.html)"
  },
  {
    "id": "b--t-cells_2008_1750165656.txt-6",
    "source_document": "b--t-cells_2008_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Negative stains",
    "url": "https://www.pathologyoutlines.com/topic/lymphomanormalBcells.html#negativestains105139",
    "clean_content": "Negative stains\n\n* B cells: [CD2](https://www.pathologyoutlines.com/topic/cdmarkerscd1.html#cd2), [CD3](https://www.pathologyoutlines.com/topic/cdmarkerscd3.html), [CD4](https://www.pathologyoutlines.com/topic/cdmarkerscd4.html), [CD8](https://www.pathologyoutlines.com/topic/cdmarkerscd8.html)* T cells: [CD19](https://www.pathologyoutlines.com/topic/cdmarkerscd19.html), [CD20](https://www.pathologyoutlines.com/topic/cdmarkerscd20.html)"
  },
  {
    "id": "b--t-cells_2008_1750165656.txt-7",
    "source_document": "b--t-cells_2008_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Additional references",
    "url": "https://www.pathologyoutlines.com/topic/lymphomanormalBcells.html#additionalreferences105140",
    "clean_content": "Additional references\n\n* [Wikipedia: B cell [Accessed 3 October 2018]](https://en.wikipedia.org/wiki/B_cell)"
  }
]